Frontlight ResearchEarly access
Spinal muscular atrophy trials in Portugal
2 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in PortugalA Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec
- Where
- Lisbon
- Age
- 0 days to 7 months
- People
- 42 worldwide
- Run by
- Biogen
See details and how to joinNCT07444450 · EU 2025-523857-32-00 - No phaseTaking peopleRegistry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
- Where
- Coimbra, Lisbon, Porto
- People
- 700 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04174157